Is PMV Pharmaceuticals, Inc. (PMVP) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1.4% / 30% | 194.2% / 30% | 0.0% / 30% | N/A | ✗ NOT HALAL |
| DJIM | 1.4% / 33% | 194.2% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| MSCI | 0.6% / 33% | 88.6% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| S&P | 1.4% / 33% | 194.2% / 33% | 0.0% / 33% | N/A | ✗ NOT HALAL |
| FTSE | 0.6% / 33% | 88.6% / 33% | 0.0% / 50% | N/A | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 0.0% | |
| Operating Margin | 0.0% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -55.4% | |
| Return on Assets (ROA) | -35.0% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$74M |
| Free Cash Flow | -$74M |
| Total Debt | $838,000 |
| Debt-to-Equity | 0.8 |
| Current Ratio | 10.1 |
| Total Assets | $117M |
Price & Trading
| Last Close | $1.35 |
| 50-Day MA | $1.29 |
| 200-Day MA | $1.32 |
| Avg Volume | 581K |
| Beta | 1.3 |
|
52-Week Range
$0.81
| |
About PMV Pharmaceuticals, Inc. (PMVP)
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Princeton, New Jersey.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is PMV Pharmaceuticals, Inc. (PMVP) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), PMV Pharmaceuticals, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is PMV Pharmaceuticals, Inc.'s debt ratio?
PMV Pharmaceuticals, Inc.'s debt ratio is 1.4% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 0.6%.
What are PMV Pharmaceuticals, Inc.'s key financial metrics?
PMV Pharmaceuticals, Inc. has a market capitalization of $70M. Return on equity stands at -55.4%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.